Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

JB Chemicals & Pharmaceuticals Ltd

+ Add to Watchlist

JBCP:IN

187.35 INR 5.65 2.93%

As of 06:06:02 ET on 01/28/2015.

Snapshot for JB Chemicals & Pharmaceuticals Ltd (JBCP)

Open: 192.00 Day's Range: 185.70 - 193.40 Volume: 115,671
Previous Close: 193.00 52wk Range: 115.10 - 257.90 1-Yr Rtn: +53.72%

Stock Chart for JBCP

No chart data available.
  • JBCP:IN 187.35
  • 1D
  • 1M
  • 1Y
193.00
Interactive JBCP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for JBCP

Current P/E Ratio (ttm) 25.8058
Estimated P/E(03/2015) 9.7578
Relative P/E vs. SENSEX 1.2569
Earnings Per Share (INR) (ttm) 7.2600
Est. EPS (INR) (03/2015) 19.2000
Est. PEG Ratio -
Market Cap (M INR) 15,888.82
Shares Outstanding (M) 84.81
30 Day Average Volume 94,495
Price/Book (mrq) 1.5223
Price/Sale (ttm) 1.5861
Dividend Indicated Gross Yield 1.60%
Cash Dividend (INR) 3.0000
Dividend Ex-Date 09/04/2014
5 Year Dividend Growth 24.57%
Next Earnings Announcement 05/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for JBCP

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for JBCP

J.B. Chemicals & Pharmaceuticals Ltd. manufactures pharmaceuticals, chemicals and agro-based products. The Group's products include metrogyl, rantac (a ranitidine-based formula), and nicardia, a cardiac care medicine. The Company has an agreement with Justesa Imagen, to manufacture and market diagnostics under the "Trazograf" brand name.

Jyotindra Bhagwanlal ModyChairman/Managing DirectorPranabh Dinesh ModyPresident/Exec Dir:Operations
Bhavesh JoshiChief Financial OfficerP K SinghPresident:Global Business
More Company Profile & Key Executives for JBCP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil